Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
The Final Grain Stocks Report may be the last key figures we see if a government shutdown halts future updates.
USDA and EPA officials aim to maintain America’s robust food supply while ensuring farmers have access to key resources and crop protection tools.
The Senate failed to pass a continuing resolution that had been approved by the House the previous week. They could take it up again today, but it would take seven democrats to end the stalemate.
The USDA is working with 14 different states, including Georgia, to develop and implement block grants to address the unique disaster recovery needs for each state.
The USDA’s August Cold Storage report shows shifting stock levels across major dairy, meat, and poultry products.